There is no denying that prostate cancer is a dreaded condition among American men. Men aged 65 or older are, however, more likely to be diagnosed with prostate cancer than men aged 45 or younger. In fact, six out of 10 men diagnosed with prostate cancer have an average age of 66. The American Cancer Society puts the number of new prostate cancer cases in 2018 at over 160 thousand. Deaths as a result of the disease, however, will be less than 30 thousand, translating to close to 18 percent. A whopping 80 percent of men diagnosed with prostate cancer will survive the disease.
Five ways to stop men dying from prostate cancer https://t.co/AaeD5HaH2P
— Dr. David Samadi (@drdavidsamadi) February 5, 2018
The high survival rate is in part possible because of the advanced technology with which urologists like Dr. David Samadi use to diagnose and treat prostate cancer. More often than not, men diagnosed with prostate cancer have to choose between surgery and radiation treatment procedures. Dr. David Samadi notes that it is an overwhelming decision, which frustrates many patients.
Dr. David Samadi’s recent article on Huff Post illustrates why surgery is the most suitable treatment method, especially if cancer is localized. Radiation is harmful to the cells of the human body and may ignite cell mutations, resulting in secondary cancers such as the bladder or rectal cancers. Moreover, statistics are in favor of surgery over radiation; Patients that opt for radiation are twice as likely to die from prostate cancer sooner than patients who are treated with surgical procedures.
Cognizant of the fact that surgery is superior to radiation as a prostate cancer treatment method, Dr. David Samadi informs prostate cancer patients that the physicians they choose to handle the disease are equally important in determining their survival rates. He vouches for experienced professionals whose records of accomplishment reflect significant successful surgeries. As an experienced urologist, he is aware of the many complications that may arise following a surgery meant to treat prostate cancer. Urinary continence and loss of sexual function are among the leading complications.
Dr. David Samadi
Based at Lenox Hill Hospital, Dr. David Samadi is among the leading urologists in the U.S. He is the head of Lenox’s urology department and robotic surgery. Dr. David Samadi’s career spanning over a decade is dedicated to the early diagnosis and treatment of prostate cancer. He is also a researcher on matters prostate cancer, and his publications have appeared in leading medical journals. He regularly makes the headlines on television, internet, social media, etc., hence the title “celebrity doctor.”
Dr. David Samadi’s Social Media: twitter.com/drdavidsamadi